Delivery Order SPE2DB20D2002-SPE2DB22FL75K
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,064.52 firm fixed-price delivery order is for the supply of Acamprosate Calcium DR 333 mg tablets, with a period of performance through November 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,064.52 firm fixed-price delivery order is for ACAMPROSATE CALC DR 333 MG TAB 180S, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,064.52 firm fixed-price delivery order is for the supply of ACAMPROSATE CALC DR 333 MG TAB 180S, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,953.54 Firm Fixed Price Delivery Order contract is for the supply of 4,564,743,033 units of Acetazolamide 250 mg tablets, a medication used to treat various medical conditions. The contract has an ultimate completion date of May 30, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a prime contractor and subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $1,266.60 firm fixed price delivery order is for the supply of Acetazolamide ER 500 mg capsules to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to...
- This federal contract award was made by the Defense Logistics Agency (DLA), a Defense agency, to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,237.36 firm fixed price Delivery Order contract is for the supply of ACETAZOLAMIDE ER 500 MG CAP 100S, a pharmaceutical product. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.22 firm fixed-price delivery order is for the supply of 100 tablets of the medication ENTACAPONE 200 MG. The contract has an ultimate completion date of May 19, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,433.18 firm fixed-price delivery order is for the supply of Acetazolamide ER 500 mg capsules, with a performance period ending on May 7, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $4,131.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical division. The contract is for the delivery of 4,562,879,147 units of acetazolamide 250 mg tablets, a generic pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,081.98 Delivery Order contract is for the supply of Acarbose 100 mg tablets. The award has an ultimate completion date of October 24, 2024 and uses a Firm Fixed Price pricing type. This contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB22FL75KDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,897.86 firm fixed-price delivery order is for the supply of 4,558,571,276 units of Acamprosate Calcium Delayed-Release 333 mg Tablets in a 180-count bottle. The award has an ultimate completion date of September 26, 2022 and was issued on September 23, 2022. No set-aside designation was used for this contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/23/22 |